NewAmsterdam Pharma grants 71,800 inducement stock options to new hires at $24.16 per share
NAMS•NewAmsterdam Pharma granted 71,800 inducement stock options and 17,745 restricted stock units to seven new hires. The options have an exercise price of $24.16 per share and vest over four years; the units vest over three years.
1. Awards to new hires
NewAmsterdam Pharma granted 71,800 inducement stock options to seven non-executive new hires under its 2024 Inducement Plan. The options have an exercise price of $24.16 per share, equal to the Oct. 1 Nasdaq closing price, and vest over four years: 25% after one year, followed by 36 equal monthly installments. The company also granted the hires 17,745 restricted stock units on Oct. 1, vesting in equal annual tranches over three years, subject to continued service.
